InvestorsHub Logo
Followers 18
Posts 643
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Friday, 05/08/2020 7:26:08 PM

Friday, May 08, 2020 7:26:08 PM

Post# of 403092
Things to consider for Brilacidin...

Likely to become the new standard of care for Oral Mucositis.

Promising results for ABSSSI as well.

Irritable Bowel disease (inflammatory conditions + resistant bacterial infestations) indications are also looking auspicious.

Now it’s being evaluated and advanced along with some other candidates for showing its efficacy in disrupting the wall of the coronavirus. (As if it’s not going to get noticed in the process?! Are you kidding? What big pharma wouldn’t want to add this gem to their collection and reap the rewards?)

Without rehashing all the terminology associated with the aforementioned positives, we’re sitting on a winner. Just a question of when the egg “hatches”.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News